Skip to main navigation Skip to search Skip to main content

Fatale miliaire tuberculose tijdens behandeling met infliximab

Translated title of the contribution: Fatal extrapulmonary tuberculosis during treatment with the immunosuppresive infliximab
  • H.E. Vonkeman*
  • , P.D.L.P.M. van der Valk
  • , M.A.F.J. van de Laar
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

A 73-year-old woman was admitted to hospital with fever whilst under treatment with infliximab for rheumatoid arthritis. Despite repeated and specific testing, tuberculosis was only diagnosed post mortem. During infliximab therapy, latent tuberculosis can reactivate in subacute form with a possible fatal outcome. For infliximab therapy to be administered safely, the risk that the patient concerned is latently infected with tuberculosis has to be estimated beforehand; if necessary a prophylactic anti-tuberculosis treatment may be given.

Translated title of the contributionFatal extrapulmonary tuberculosis during treatment with the immunosuppresive infliximab
Original languageDutch
Pages (from-to)1196-1199
Number of pages4
JournalNederlands tijdschrift voor geneeskunde
Volume146
Issue number25
Publication statusPublished - 22 Jun 2002
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 2020 OA procedure

Fingerprint

Dive into the research topics of 'Fatal extrapulmonary tuberculosis during treatment with the immunosuppresive infliximab'. Together they form a unique fingerprint.

Cite this